US Stock MarketDetailed Quotes
MDXG MiMedx
- 6.160
- -0.170-2.69%
Close Apr 18 16:00 ET
- 6.160
- 0.0000.00%
Post 16:20 ET
905.26MMarket Cap16.65P/E (TTM)
6.390High6.155Low542.39KVolume6.340Open6.330Pre Close3.37MTurnover0.47%Turnover Ratio16.65P/E (Static)146.96MShares9.27052wk High6.34P/B715.82MFloat Cap3.49052wk Low--Dividend TTM116.20MShs Float18.250Historical High--Div YieldTTM3.71%Amplitude0.309Historical Low6.213Avg Price1Lot Size
MiMedx Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.03%321.48M | 16.75%86.83M | 20.72%81.71M | 21.49%81.26M | 21.70%71.68M | 10.67%267.84M | 46.37%74.38M | 7.32%67.69M | -1.88%66.88M | -1.79%58.89M |
| Operating revenue | 20.03%321.48M | 20.82%117.18M | 17.67%70.3M | 21.49%81.26M | 21.70%71.68M | 10.67%267.84M | 90.88%96.99M | -5.28%59.75M | -1.88%66.88M | -1.79%58.89M |
| Cost of revenue | 13.08%54.63M | -3.67%13.84M | 21.35%14.79M | 14.89%13.58M | 24.99%12.42M | 21.92%48.32M | 102.44%14.37M | 20.33%12.19M | -7.34%11.82M | 3.06%9.94M |
| Gross profit | 21.55%266.84M | 21.64%72.99M | 20.58%66.92M | 22.91%67.67M | 21.04%59.26M | 8.47%219.53M | 37.27%60.01M | 4.83%55.5M | -0.62%55.06M | -2.72%48.96M |
| Operating expense | -1.93%229.73M | 1.78%49.56M | -10.71%55.9M | -4.74%61.63M | 7.52%62.64M | 11.87%234.25M | 14.91%48.7M | 15.89%62.6M | 15.91%64.7M | 1.89%58.26M |
| Selling and administrative expenses | 1.17%211.12M | 9.06%54.35M | -1.69%52.57M | -6.93%51.93M | 5.46%52.28M | 7.10%208.67M | 0.57%49.84M | 15.52%53.48M | 4.09%55.79M | 9.18%49.57M |
| Research and development costs | -0.28%12.67M | -16.39%-5.5M | -46.67%3.18M | 54.15%8.5M | 8.92%6.5M | 27.88%12.7M | -66.60%-4.73M | 36.29%5.95M | 35.66%5.51M | 37.45%5.96M |
| Depreciation amortization depletion | 8.70%762K | 5.49%192K | 8.57%190K | 10.40%191K | 10.47%190K | -14.51%701K | 5.20%182K | -9.33%175K | -19.53%173K | -28.03%172K |
| -Depreciation and amortization | 8.70%762K | 5.49%192K | 8.57%190K | 10.40%191K | 10.47%190K | -14.51%701K | 5.20%182K | -9.33%175K | -19.53%173K | -28.03%172K |
| Other operating expenses | -57.49%5.18M | -84.62%524K | -101.27%-38K | -68.40%1.02M | 43.93%3.67M | 221.21%12.18M | 175.47%3.41M | -5.33%3M | 256.06%3.22M | -64.54%2.55M |
| Operating profit | 352.03%37.12M | 107.11%23.43M | 255.20%11.02M | 162.72%6.04M | 63.65%-3.38M | -110.45%-14.73M | 745.37%11.31M | -560.74%-7.1M | -2,250.24%-9.64M | -35.73%-9.3M |
| Net non-operating interest income expense | -28.73%-6.46M | -9.86%-1.59M | -32.28%-1.68M | -39.32%-1.63M | -37.92%-1.55M | -0.72%-5.02M | -23.51%-1.45M | -31.88%-1.27M | 14.66%-1.17M | 23.51%-1.13M |
| Non-operating interest expense | 28.73%6.46M | 9.86%1.59M | 32.28%1.68M | 42.38%1.52M | 37.92%1.55M | 0.72%5.02M | 23.51%1.45M | 31.88%1.27M | -22.03%1.07M | -23.51%1.13M |
| Total other finance cost | ---- | ---- | ---- | 6.93%108K | ---- | ---- | ---- | ---- | --101K | ---- |
| Other net income (expense) | -550.00%-26K | 116,100.00%3.48M | -219K | -3.29M | 2K | 94.74%-4K | 95.89%-3K | |||
| Special income (charges) | --0 | --3.46M | ---208K | ---3.26M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less：Restructuring and merger&acquisition | ---- | ---- | --208K | --3.26M | ---- | ---- | ---- | --0 | --0 | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -550.00%-26K | 633.33%16K | ---11K | ---32K | --2K | 82.61%-4K | 85.00%-3K | ---- | ---- | ---- |
| Income before tax | 255.13%30.63M | 156.78%25.31M | 208.98%9.13M | 110.42%1.13M | 52.70%-4.93M | -63.82%-19.75M | 10,732.97%9.86M | -310.84%-8.37M | -505.72%-10.81M | -25.25%-10.43M |
| Income tax | -17,966.99%-36.81M | -133,582.14%-37.38M | 1,015.09%591K | -219.35%-74K | -19.05%51K | -16.60%206K | 125.93%28K | -82.39%53K | 1,340.00%62K | 8.62%63K |
| Net income | 437.99%67.44M | 537.72%62.69M | 201.28%8.53M | 111.04%1.2M | 52.49%-4.98M | -62.21%-19.95M | 4,839.70%9.83M | -260.24%-8.43M | -510.91%-10.87M | -25.14%-10.49M |
| Net income continuous Operations | 437.99%67.44M | 537.72%62.69M | 201.28%8.53M | 111.04%1.2M | 52.49%-4.98M | -62.21%-19.95M | 4,839.70%9.83M | -260.24%-8.43M | -510.91%-10.87M | -25.14%-10.49M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 437.99%67.44M | 537.72%62.69M | 201.28%8.53M | 111.04%1.2M | 52.49%-4.98M | -62.21%-19.95M | 4,839.70%9.83M | -260.24%-8.43M | -510.91%-10.87M | -25.14%-10.49M |
| Preferred stock dividends | 2.63%6.75M | -7.49%1.57M | 6.17%1.77M | 6.14%1.73M | 6.18%1.68M | 26.30%6.58M | 6.20%1.7M | 6.10%1.67M | 57.60%1.63M | 57.65%1.59M |
| Other preferred stock dividends | 4.89M | 0 | 0 | 0 | ||||||
| Net income attributable to common stockholders | 310.29%55.8M | 591.28%56.23M | 166.97%6.76M | 95.77%-528K | 44.79%-6.67M | -43.91%-26.53M | 681.83%8.13M | -158.01%-10.1M | -281.44%-12.5M | -22.59%-12.08M |
| Basic earnings per share | 221.21%0.4 | 2,118.74%0.4037 | 166.67%0.06 | 95.86%-0.0046 | 45.45%-0.06 | -120.00%-0.33 | -300.00%-0.02 | -125.00%-0.09 | -266.67%-0.11 | -22.22%-0.11 |
| Diluted earnings per share | 212.12%0.37 | 2,022.66%0.3845 | 166.67%0.06 | 95.86%-0.0046 | 45.45%-0.06 | -120.00%-0.33 | -300.00%-0.02 | -125.00%-0.09 | -266.67%-0.11 | -22.22%-0.11 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg